Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01066702 · ClinicalTrials.gov registry record · Phase 3
Confirmatory Study of NeoCart in Knee Cartilage Repair
A Phase 3 study, sponsored by Histogenics Corporation.
- Terminated
- Registry status
- Phase 3
- Development phase
- 245
- Enrollment target
NCT01066702 is a Phase 3 study that was terminated before completion, run by Histogenics Corporation. The registered enrollment target is 245 participants.
The verdict
NCT01066702, a Phase 3 study, was terminated before completion, sponsored by Histogenics Corporation.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 245 participants
- Enrollment target
Study Summary
This confirmatory study is a prospective randomized trial comparing the efficacy and safety of an autologous chondrocyte tissue implant (NeoCart) to the surgical intervention microfracture in the treatment of cartilage defects in the knee.
Interventions
- PROCEDURE Microfracture
- BIOLOGICAL NeoCart
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 245 participants |
| Start Date | 2010-05 |
| Est. Completion | 2019-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01066702
The ClinicalTrials.gov registry entry for NCT01066702 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 245 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Histogenics Corporation, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Microfracture is the first listed.
NCT01066702 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01066702 about?
NCT01066702 is a clinical study titled "Confirmatory Study of NeoCart in Knee Cartilage Repair". This confirmatory study is a prospective randomized trial comparing the efficacy and safety of an autologous chondrocyte tissue implant (NeoCart) to the surgical intervention microfracture in the treatment of cartilage defects in the knee.
What is the current status of trial NCT01066702?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 245 participants. The study started on 2010-05. Estimated completion is 2019-03.
What interventions are being tested in trial NCT01066702?
The interventions under investigation include: Microfracture (PROCEDURE), NeoCart (BIOLOGICAL).
Who is sponsoring clinical trial NCT01066702?
This trial is sponsored by Histogenics Corporation, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.